Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation
Authors:
- Derek K. SmithDSDerek K. Smith
- Lance KatesLKLance Kates
- Steffen DurinckSDSteffen Durinck
- Nisha PatelNPNisha Patel
- Eric W. StawiskiESEric W. Stawiski
- Noelyn KljavinNKNoelyn Kljavin
- Oded ForemanOFOded Foreman
- Bence SiposBSBence Sipos
- Mark J. SollowayMSMark J. Solloway
- Bernard B. AllanBABernard B. Allan
- Andrew S. PetersonAPAndrew S. Peterson
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 1 (5)
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pancreatic neuroendocrine tumors: biology, diagnosis,and treatmentChinese Journal of Cancer, 2013
- Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical ExperienceCancer Research, 2013
- Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetesBMC Genomics, 2011
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- Everolimus for Advanced Pancreatic Neuroendocrine TumorsNew England Journal of Medicine, 2011
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine TumorsNew England Journal of Medicine, 2011
- Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell TumorPancreas, 2009
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survivalAnnals of Oncology, 2008
- Lack of Efficacy of Streptozocin and Doxorubicin in Patients With Advanced Pancreatic Endocrine TumorsAmerican Journal of Clinical Oncology, 2004
- Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout miceProceedings of the National Academy of Sciences, 2003